Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,310,718
in 4 filings, $1.2M under 10b5-1 plans

Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-03 Raykov Rosty CHIEF EXECUTIVE OFFICER Option exercise +74,793 $1.59 $119K 307,631
2023-11-03 Raykov Rosty CHIEF EXECUTIVE OFFICER Option exercise · Option Contract −74,793 $1.59 $119K 1,596,040
2023-08-18 RALLIS CHRIS A Director Sale 10b5-1 −673 $7.85 $5K 43,303
2023-08-07 Haigh Adrian CHIEF OPERATING OFFICER Grant or award · Stock Option +200,000 493,579
2023-07-24 RALLIS CHRIS A Director Option exercise 10b5-1 +16,666 $0.72 $12K 50,772
2023-07-24 RALLIS CHRIS A Director Sale 10b5-1 −6,796 $8.17 $56K 43,976
2023-07-24 RALLIS CHRIS A Director Option exercise · Common Shares 10b5-1 −16,666 $0.72 $12K 187,312
2023-07-06 RALLIS CHRIS A Director Sale 10b5-1 −2,207 $8.47 $19K 28,826
2023-07-06 RALLIS CHRIS A Director Option exercise 10b5-1 +5,280 $0.96 $5K 34,106
2023-07-06 RALLIS CHRIS A Director Option exercise · Common Shares 10b5-1 −5,208 $0.96 $5K 203,978
2023-06-30 Andrade Robert CHIEF FINANCIAL OFFICER Sale 10b5-1 −7,500 $8.82 $66K 124,721
2023-06-30 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise 10b5-1 +25,000 $2.45 $61K 149,721
2023-06-30 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise · Common Shares 10b5-1 −25,000 $2.45 $61K 605,000
2023-06-29 Andrade Robert CHIEF FINANCIAL OFFICER Sale 10b5-1 −7,500 $8.97 $67K 132,221
2023-06-28 Andrade Robert CHIEF FINANCIAL OFFICER Sale 10b5-1 −10,000 $8.99 $90K 139,721
2023-06-12 Islam Khalid Director Grant or award · Stock Option +25,000 388,825
2023-06-12 Cook Jodi A Director Grant or award · Stock Options +20,000 100,000
2023-06-12 RALLIS CHRIS A Director Grant or award · Stock Option +20,000 209,186
2023-06-12 Brughera Marco Maria Director Grant or award · Stock Option +20,000 175,545
2023-06-12 Haigh Adrian Director Grant or award · Stock Option +20,000 293.58

Page 17 of 17 · 340 trades